PLA/BG MEMBRANE LOADED WITH CIPROFLOXACIN FOR TREATING INFECTIONS.

Fig 1: The results revealed a porous, flexible and sheet-like morphology.

Fig 2: The percentage of tissue viability was nearly the same as the control sample which gives a positive finding.

Fig 3:  The formed compound was found to be hydrophilic with the contact angle.

Fig 4: Results also showed the presence of hydroxyl, carboxyl, carbonate, phosphate, amide and amine groups in the synthesised membrane.

The amalgamation of polylactic acid (PLA) and bioactive glass (BG) membranes loaded with ciprofloxacin presents a multifaceted approach to combat antibiotic-resistant infections, addressing both the limitations of systemic therapy and the need for localized, targeted interventions(10)(11).

Developing PLA based composites is one of the major methods to address the problems associated with PLA in biomedicine. Blend of other materials with PLA may provide balanced physical and biological properties. In recent years, incorporation of nanoparticles within PLA has been developed to achieve further performance improvement. Nanocomposites have attracted much attention due to their unique properties(12).  Tissue engineering uses engineering principles and life sciences to develop biologically active substitutes with the aim of restoring damaged tissues and improving their functions. An engineered tissue starts by a scaffold able to support the migration and growth of cells that will originate the new tissue. Those porous scaffolds are able to guide the implanted cells to form a new tissue showing a well-integrated structure after scaffold degradation(12,13).

Synergistic Biocompatibility and Antibacterial Efficacy:

The choice of PLA and BG as the base materials for our membranes stems from their proven biocompatibility and ability to promote tissue regeneration. The combination capitalizes on BG’s osteogenic properties and PLA’s biodegradability, creating a scaffold that not only interfaces seamlessly with biological tissues but also offers structural support(12–14).

Ciprofloxacin, a fluoroquinolone with broad-spectrum antibacterial activity, complements this biomaterial duo. The sustained release of ciprofloxacin from the membranes provides a continuous and localized antibacterial effect, crucial for eradicating pathogens in specific anatomical sites.

Controlled Drug Release Kinetics:

Our study meticulously examined the drug release kinetics of ciprofloxacin from the PLA/BG membranes. The controlled release profile ensures a sustained therapeutic concentration over an extended period, maximizing the drug’s efficacy while minimizing the risk of systemic side effects associated with conventional antibiotic treatments(15).

This controlled release mechanism not only enhances the therapeutic window of ciprofloxacin but also allows for tailored interventions based on the specific requirements of the infection site, promoting patient-centered precision medicine(15,16).

In Vitro Antibacterial Efficacy:

The in vitro models employed in our study provided valuable insights into the antibacterial efficacy of the PLA/BG membranes loaded with ciprofloxacin. The results demonstrated a notable reduction in bacterial growth, affirming the potential of this approach for localized infection treatment(17,18).

The ability of these membranes to create a hostile environment for bacteria while maintaining compatibility with host tissues positions them as promising candidates for various clinical applications, ranging from wound dressings to implant coatings.

Clinical Implications and Future Directions:

The outcomes of our research hold implications for the development of advanced biomaterials tailored for localized infection management. Clinical translation of this technology could revolutionize current practices in wound care, surgical procedures, and implantable medical devices(19).

Future investigations should focus on refining the membrane composition, optimizing drug release kinetics, and expanding the scope of in vivo studies. Long-term biocompatibility, potential immunogenic responses, and scalability for clinical applications are crucial considerations that warrant further exploration. Also the present study concentrates mostly on the oral infections which can be expanded on a broader spectrum to utilize it as an aid for systemic infections too(20,21). The future study could also concentrate on other drugs and implants that can be loaded and used effectively.

In conclusion, the PLA/BG membranes loaded with ciprofloxacin exhibit a promising synergy between biomaterials and antibiotic therapy. This study contributes to the evolving landscape of infection treatment, offering a glimpse into the potential of precision medicine in addressing the challenges posed by antibiotic-resistant infections. As we continue to unravel the intricacies of this approach, its transformative impact on localized infection management becomes increasingly evident, heralding a paradigm shift in the way we combat bacterial pathogens.

The study concludes that the synthesized PLA/ BG membrane is an effective compound to treat both oral and systemic infections wherein PLA serves its stable and biocompatible properties and helps the membrane from not degrading faster. Bioglass containing calcium, sodium, phosphate, silicon has good adsorption, releasing property and also helps in regeneration of tissues. Bioglass also has a higher cell proliferation rate. Additionally the loaded ciprofloxacin helps in healing of infected tissues.